EUVIMEDEUVIMED entdecken
Leserbrief

Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure

Yakup Demir iD

Alimentary Pharmacology & Therapeutics · 16.10.2026

DOI: 10.1111/apt.71059 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 16.10.2026. Verfasst von Yakup Demir. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Memorial Diyarbakir Hospital, Diyarbakir, Turkiye. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Infectious Diseases and Clinical Microbiology, Memorial Diyarbakir Hospital, Diyarbakir, Turkiye.

ORCID-Profile: Yakup Demir

Zitieren

APA

Demir, Y. (2026). Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71059

Vancouver

Demir Y. Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71059

BibTeX
@article{Demir2026,
  author = {Demir, Yakup},
  title = {Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.71059}
}
Kostenlos starten →